In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery
Join us on Monday, October 26, to learn about the role serology plays in the clinician toolbox for managing COVID-19
Explore exclusive interviews, new methods, and free download to help optimize your 3D cell culture
Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format
We reveal the cell counters, LC systems and particle size analyzer that have earned one of these coveted awards based on exceptional reviewer feedback
Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
StemFit for mesenchymal stem cells (MSC) is the latest addition to the StemFit family of stem cell media
We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease
Affimer-based research assay launched alongside performance data published by Bruker
A comprehensive and interactive digital guide, to real-time live-cell imaging and analysis
Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays
Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
Join us on Monday, September 21, to learn about assay development for high-throughput screening
Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development
The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays
IgM assay has 95.51% positive predictive value even when disease incidence is only 3%
Leveraging GenMark’s eSensor XT-8 platform hopes to expand COVID-19 diagnostic testing capacity
Watch this on-demand webinar to learn all about the new alternative to live virus neutralization and immunoglobulin detection
Enables labs to quickly ramp up testing capacity and generate results faster
